NASDAQ · Financial Statements

QuidelOrtho Corporation (QDEL) Revenue, Earnings & Financial Statements

$10.52 NASDAQ: QDEL Market Cap $721.46M

Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

QuidelOrtho Corporation most recently reported annual revenue of $2.7B, a net loss of $1.1B. Revenue grew at an average annual rate of 10.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

QuidelOrtho Corporation: Revenue rose from $192.0M in 2016 to $2.7B in 2025, a change of +1321.9% over 9 years; net profit was positive in 5 of 10 reported years; operating margin moved from -2.3% to -33.7%, a shift of -31.4 percentage points; the most recent year shows a net loss of $1.1B.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$192.0M$278.0M$522.0M$535.0M$1.7B$1.7B$3.3B$3.0B$2.8B$2.7B
Operating Expenses$196.0M$268.0M$426.0M$442.0M$601.0M$793.0M$2.4B$2.9B$4.7B$3.6B
Operating Profit−$4.0M$10.0M$96.0M$93.0M$1.1B$906.0M$844.0M$139.0M−$2.0B−$919.0M
Operating Margin-2.3%3.4%18.4%17.3%63.8%53.3%25.8%4.6%-70.5%-33.7%
Other Income−$12.0M−$18.0M−$33.0M−$16.0M−$20.0M−$6.0M−$108.0M−$168.0M−$171.0M−$188.0M
Interest$12.0M$18.0M$24.0M$15.0M$1.0M$1.0M$75.0M$179.0M$188.0M$178.0M
Depreciation$23.0M$31.0M$46.0M$48.0M$49.0M$53.0M$284.0M$457.0M$453.0M$442.0M
Profit Before Tax−$16.0M−$8.0M$63.0M$77.0M$1.0B$900.0M$736.0M−$29.0M−$2.1B−$1.1B
Tax rate (%)14.8%-1.6%-17.0%5.5%22.1%21.8%25.4%65.3%3.7%-2.2%
Net Profit−$14.0M−$8.0M$74.0M$73.0M$810.0M$704.0M$549.0M−$10.0M−$2.1B−$1.1B
EPS−$0.42−$0.24$1.74$1.73$18.60$16.43$9.56−$0.15−$30.54−$16.69

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$743.0M$711.0M$637.0M$727.0M$708.0M$693.0M$614.0M$700.0M$724.0M$620.0M$631.0M$619.0M
Operating Expenses$703.0M$2.5B$755.0M$712.0M$808.0M$660.0M$795.0M$1.4B$790.0M$647.0M$653.0M$626.0M
Operating Profit$40.0M−$1.8B−$117.0M$15.0M−$100.0M$33.0M−$181.0M−$705.0M−$66.0M−$27.0M−$22.0M−$7.0M
Operating Margin5.4%-247.3%-18.4%2.1%-14.2%4.7%-29.4%-100.7%-9.2%-4.4%-3.5%-1.2%
Interest$46.0M$32.0M$48.0M$50.0M$45.0M$42.0M$46.0M$46.0M$43.0M$51.0M$55.0M$55.0M
Profit Before Tax−$9.0M−$1.8B−$163.0M−$29.0M−$141.0M−$9.0M−$230.0M−$757.0M−$112.0M−$79.0M−$81.0M−$63.0M
Tax rate (%)176.1%5.2%9.3%30.9%-26.6%-44.3%-11.2%3.2%-16.3%-15.5%-14.4%14.5%
Net Profit$7.0M−$1.7B−$148.0M−$20.0M−$178.0M−$13.0M−$255.0M−$733.0M−$131.0M−$92.0M−$93.0M−$54.0M
EPS$0.10−$25.50−$2.20−$0.30−$2.28−$0.19−$3.77−$10.78−$1.95−$1.35−$1.36−$0.78

Over the 10 years reported for QuidelOrtho Corporation, borrowings increased from $148.0M in 2016 to $2.8B in 2025, cash stood at $170.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.50 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$388.0M$935.0M$806.0M$911.0M$1.9B$2.4B$8.9B$8.6B$6.4B$5.8B
Current Assets$225.0M$331.0M$193.0M$222.0M$1.1B$1.4B$1.6B$1.3B$1.2B$1.4B
Cash$170.0M$36.0M$44.0M$53.0M$490.0M$803.0M$293.0M$119.0M$98.0M$170.0M
Inventory$26.0M$67.0M$67.0M$58.0M$114.0M$199.0M$524.0M$578.0M$534.0M$578.0M
Receivables$25.0M$78.0M$77.0M$102.0M$529.0M$394.0M$586.0M$488.0M$451.0M$417.0M
Fixed Assets$51.0M$62.0M$74.0M$172.0M$211.0M$477.0M$1.5B$1.6B$1.5B$1.5B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$64.0M$73.0M$56.0M$22.0M$32.0M
Other Assets$84.0M$337.0M$337.0M$337.0M$337.0M$337.0M$2.5B$2.5B$650.0M$0
Total Liabilities$188.0M$708.0M$381.0M$351.0M$538.0M$501.0M$3.9B$3.6B$3.4B$3.8B
Current Liabilities$34.0M$128.0M$160.0M$126.0M$337.0M$324.0M$1.0B$834.0M$999.0M$966.0M
Borrowings$148.0M$397.0M$108.0M$112.0M$109.0M$139.0M$2.8B$2.6B$2.7B$2.8B
Other Liabilities$39.0M$311.0M$273.0M$239.0M$430.0M$362.0M$1.1B$943.0M$758.0M$1.0B
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$201.0M$227.0M$426.0M$560.0M$1.3B$1.9B$4.9B$5.0B$3.0B$1.9B

For QuidelOrtho Corporation, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was negative at $83.0M; free cash flow was positive in 7 of 10 years; financing activities used $5.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$12.0M$28.0M$136.0M$134.0M$630.0M$806.0M$885.0M$280.0M$83.0M$105.0M
Investing Cash Flow−$29.0M−$449.0M$230.0M−$54.0M−$128.0M−$612.0M−$1.8B−$397.0M−$345.0M−$381.0M
Financing Cash Flow−$20.0M−$10.0M−$59.0M−$60.0M−$92.0M−$180.0M−$121.0M−$51.0M−$10.0M−$5.0M
Net Cash Flow−$22.0M−$133.0M$8.0M$9.0M$437.0M$313.0M−$509.0M−$174.0M−$21.0M$71.0M
Free Cash Flow$0$10.0M$105.0M$107.0M$565.0M$513.0M$744.0M$71.0M−$112.0M−$83.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA11.27
FCF Yield-16.04%
Quick Ratio0.75
Interest Coverage-0.60
Return 1Y-51.69%
Return 3Y-82.45%
Return 5Y-91.71%

QuidelOrtho Corporation (QDEL) financials — frequently asked questions

What is QuidelOrtho Corporation's annual revenue?

QuidelOrtho Corporation (QDEL) reported annual revenue of $2.7B in its most recent fiscal year.

What is QuidelOrtho Corporation's net profit?

QuidelOrtho Corporation (QDEL) reported a net loss of $1.1B in its most recent fiscal year.

What is QDEL EV/EBITDA?

QuidelOrtho Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is 11.27.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BSTE revenue $5.9BMLAB revenue $249.0MMOBI stockSI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MSKIN revenue $301.0MNYXH revenue $10.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
QDEL Overview QDEL Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.